Non-Myeloablative Allogeneic Transplantation with Post-Transplant Cyclophosphamide after Immune Checkpoint Inhibition for Classic Hodgkin Lymphoma: A Retrospective Cohort Study-Reference-Cited by-同舟云学术

Non-Myeloablative Allogeneic Transplantation with Post-Transplant Cyclophosphamide after Immune Checkpoint Inhibition for Classic Hodgkin Lymphoma: A Retrospective Cohort Study

Published:2020-09 Issue:9 Volume:26 Page:1679-1688
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Paul Suman,Zahurak Marianna,Luznik Leo,Ambinder Richard F.,Fuchs Ephraim J.,Bolaños-Meade Javier,Wagner-Johnston Nina,Swinnen Lode J.,Schoch Laura,Varadhan Ravi,Jones Richard J.,Gladstone Douglas E.

Funder

Society for Immunotherapy of Cancer

National Institutes of Health

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference32 articles.

1. Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial;Younes;Lancet Oncol,2016

2. Phase II study of the efficacy and safety of pembrolizumab for relapsed/refractory classic Hodgkin lymphoma;Chen;J Clin Oncol,2017

3. Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphoma;Castagna;Bone Marrow Transplant,2017

4. T Cell-Replete Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for Hodgkin Lymphoma Relapsed after Autologous Transplantation: Reduced Incidence of Relapse and of Chronic Graft-versus-Host Disease Compared with HLA-Identical Related Donors

5. Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation as Alternative to Matched Sibling or Unrelated Donor Transplantation for Hodgkin Lymphoma: A Registry Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-PD-1 combined with hypomethylating agent and CAG regimen bridging to allogeneic hematopoietic stem cell transplantation: a novel strategy for relapsed/refractory acute myeloid leukemia;Frontiers in Immunology;2024-08-16

2. PTCy vs CNI–based GVHD prophylaxis in HLA-matched transplants for Hodgkin lymphoma: a study of the LWP of the EBMT;Blood Advances;2024-07-26

3. Graft Failure Incidence, Risk Factors, and Outcomes in Patients Undergoing Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide;Transplantation and Cellular Therapy;2024-06

4. Clinical Experiences with Immune Checkpoint Inhibitors in Lymphomas;Precision Cancer Therapies vol 2 ‐ Immunologic Approaches for the Treatment of Lymphoid Malignancies ‐ From Concept to Practice;2024-02-21

5. Immune checkpoint blockade in hematological malignancies: current state and future potential;Frontiers in Oncology;2024-01-23